Terms: = Endocrine gland cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Prognosis
9 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Cell-in-Cell-Mediated Entosis Reveals a Progressive Mechanism in Pancreatic cancer.
Song J; Xu R; Zhang H; Xue X; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Gastroenterology; 2023 Dec; 165(6):1505-1521.e20. PubMed ID: 37657757
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract] [Full Text] [Related]
4. A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic cancer.
Xiao M; Liang X; Yan Z; Chen J; Zhu Y; Xie Y; Li Y; Li X; Gao Q; Feng F; Fu G; Gao Y
Front Immunol; 2022; 13():803962. PubMed ID: 35222383
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Capicua on Pancreatic cancer Progression.
Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
[TBL] [Abstract] [Full Text] [Related]
6. Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma.
Hayashi A; Yavas A; McIntyre CA; Ho YJ; Erakky A; Wong W; Varghese AM; Melchor JP; Overholtzer M; O'Reilly EM; Klimstra DS; Basturk O; Iacobuzio-Donahue CA
Mod Pathol; 2020 Sep; 33(9):1822-1831. PubMed ID: 32350415
[TBL] [Abstract] [Full Text] [Related]
7. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract] [Full Text] [Related]
8. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.
Bonneau C; Rouzier R; Geyl C; Cortez A; Castela M; Lis R; Daraï E; Touboul C
Gynecol Oncol; 2015 Jan; 136(1):112-20. PubMed ID: 25449309
[TBL] [Abstract] [Full Text] [Related]
9. Levels of circulating immune complexes in patients with ovarian cancer.
Clarke AG; Vasey DP; Symonds EM; Faratian B; McLaughlin PJ; Price MR; Baldwin RW
Br J Obstet Gynaecol; 1982 Mar; 89(3):231-7. PubMed ID: 7066260
[TBL] [Abstract] [Full Text] [Related]